Jefferies Group's BIO Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 4,605 shares of Bio-Rad Laboratories, Inc. (BIO) worth $1.74 M, representing 0.01% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in BIO, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 7,065 shares. Largest reduction occurred in Q2 2023, reducing 9,065 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Bio-Rad Laboratories (BIO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Rad Laboratories (BIO) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +4,605 | New Buy | 4,605 | $377.71 |
| Q1 2026 | -1,445 | Sold Out | 0 | $0.00 |
| Q4 2025 | +1,445 | New Buy | 1,445 | $302.99 |
| Q3 2025 | -3,300 | Sold Out | 0 | $0.00 |
| Q2 2025 | +3,300 | New Buy | 3,300 | $241.32 |
| Q1 2025 | -1,807 | Sold Out | 0 | $0.00 |
| Q4 2024 | -5,258 | Reduce 74.42% | 1,807 | $328.51 |
| Q3 2024 | +7,065 | New Buy | 7,065 | $334.58 |
| Q2 2024 | -695 | Sold Out | 0 | $0.00 |
| Q1 2024 | -1,305 | Reduce 65.25% | 695 | $345.87 |
| Q4 2023 | +1,265 | Add 172.11% | 2,000 | $322.89 |
| Q3 2023 | -200 | Reduce 21.39% | 735 | $358.45 |
| Q2 2023 | -9,065 | Reduce 90.65% | 935 | $379.12 |
| Q1 2023 | -6,527 | Reduce 39.49% | 10,000 | $479.02 |
| Q4 2022 | +16,527 | New Buy | 16,527 | $420.49 |
Jefferies Group's Bio-Rad Laboratories Investment FAQs
Jefferies Group first purchased Bio-Rad Laboratories, Inc. (BIO) in Q4 2022, acquiring 16,527 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Bio-Rad Laboratories, Inc. (BIO) for 15 quarters since Q4 2022.
Jefferies Group's largest addition to Bio-Rad Laboratories, Inc. (BIO) was in Q4 2022, adding 16,527 shares worth $6.95 M.
According to the latest 13F filing for Q3 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 4,605 shares of Bio-Rad Laboratories, Inc. (BIO), valued at approximately $1.74 M.
As of the Q3 2026 filing, Bio-Rad Laboratories, Inc. (BIO) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Bio-Rad Laboratories, Inc. (BIO) was 16,527 shares, as reported at the end of Q4 2022.